Publication:
Recent Advances in Allergen-Specific Immunotherapy as Treatment for Allergic Asthma: A Practical Overview.

No Thumbnail Available

Date

2021-02-25

Authors

Tabar, Ana I
Delgado, Julio
González-Mancebo, Eloina
Arroabarren, Esozia
Soto Retes, Lorena
Domínguez-Ortega, Javier
Spanish Allergy and Clinical Immunology Scientific Society (SEAIC)

Advisors

Journal Title

Journal ISSN

Volume Title

Publisher

Metrics
Google Scholar
Export

Research Projects

Organizational Units

Journal Issue

Abstract

The Global Initiative for Asthma Report updated in 2019 stated that potential benefits of allergen immunotherapy (AIT), compared to pharmacological and avoidance options, must be weighed against the risk of adverse effects and the inconvenience and cost of the prolonged course of therapy in asthma. Thus, with the aim of clarifying some aspects with regard to the possible use of AIT in allergic asthma treatment armamentarium, a group of expert allergists from the Spanish Allergy and Clinical Immunology Scientific Society (SEAIC), particularly from the Immunotherapy and Asthma Interest Groups developed a frequently asked questions in clinical practice. This document updates relevant topics on the use of AIT in asthma and could facilitate physician clinical decisions and improve health outcomes for individual patients.

Description

MeSH Terms

Age Factors
Allergens
Antibody Specificity
Asthma
Biomarkers
Clinical Decision-Making
Clinical Trials as Topic
Cost-Benefit Analysis
Desensitization, Immunologic
Disease Management
Humans
Immunoglobulin E
Prognosis
Severity of Illness Index
Treatment Outcome

DeCS Terms

CIE Terms

Keywords

Allergy, Asthma, Clinical practice, Immunotherapy

Citation